1. Marincola, P.M. & Rosenberg, S.A. Biologic therapy with interleukin-2: Preclinical studies. in: Biologic Therapy of Cancer. (eds. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) 250–262 (Lippincott, Philadelphia, 1995).
2. Kirkwood, J.M. Biologic therapy with interferon-α and β: Clinical applications. in: Biologic Therapy of Cancer. (eds. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) 388–411 (Lippincott, Philadelphia, 1995).
3. Houghton, A.N. & Chapman, P.B. Clinical applications of monoclonal antibodies in cancer. in: Biologic Therapy of Cancer. (eds. DeVita, V.T., Jr., Hellman, S. & Rosenberg, S.A.) 576–590 (Lippincott, Philadelphia, 1995).
4. Van Der Bruggen, P. et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643–1647 (1991).
5. Halaban, R., Kwon, B.S., Ghosh, S., Delli-Bovi, P. & Baird, A. bFGF as an autocrine growth factor for human melanomas. Oncogene Res. 3, 177–186 (1988).